Research output per year
Research output per year
Personal profile
Research Biography
Dr Morton is a subject matter expert on multi-centre clinical trials and health data. She leads the Health Data & Clinical Trials, & is passionate about translating research locally, nationally, and internationally to improve health. She has over 20 years of experience across the full gamut of both academic & industry clinical trials from Phase I to Phase IV, plus national registries, and has research expertise as an ethics specialist, clinical research associate (monitor), study coordinator, project manager, data manager, pharmacy technician, laboratory technician, pharmacokinetic statistician, operations manager (including contracts and budgets), community representative, and of course Chief Investigator.
Education/Academic qualification
PhD
Bachelor of Biotechnology (Honours)
Fingerprint
Dive into the research topics where Erin Morton is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
ENLIGHTEN: homEbouNd peopLe agInG witH TEchNology: Holding the suspension bridge of ongoing high-quality care
Pinero de Plaza, M. A., Dafny, H., Lawless, M., McMillan, P., Buchanan, R., Leon, Z., Beleigoli, A., Archibald, M., Mudd, A., Lange, B., Tieu, M., Feo, R., Visvanathan, R., Clark, R., Hendriks, J., Hallmann, G., Del Fante, P., Morton, E., Hunter, S. C. & Kitson, A., 22 Nov 2022.Research output: Contribution to conference › Abstract › peer-review
Open Access -
Outcomes of a pilot study evaluating a nurse-led clinic to reduce burden of cardiovascular disease risk in women with breast cancer
Kemp, E., Wilson, T., Clark, R., Lawn, S., Morton, E., Ullah, S., Hunt, L., Selvanayagam, J. B. & Koczwara, B., 2022, p. 33-33. 1 p.Research output: Contribution to conference › Abstract › peer-review
-
Predicting the implementation impact of RAPIDx AI in South Australian emergency departments
Pinero de Plaza, M. A., Lambrakis, K., Barrera Causil, C. J., Marmolejo Ramos, F., Chew, D., Beleigoli, A., Lawless, M., Archibald, M., Mudd, A., McMillan, P., Morton, E., Ambagtsheer, R., Khan, E., Clark, R., Visvanathan, R., Yadav, L. & Kitson, A., 28 Oct 2022, p. 1. 1 p.Research output: Contribution to conference › Poster › peer-review
-
PROLIFERATE: A Tool to Measure Impact and Usability of AI-Powered Technologies
Pinero de Plaza, M. A., Lambrakis, K., Morton, E., Beleigoli, A., Lawless, M., McMillan, P., Archibald, M., Ambagtsheer, R., Khan, E., Mudd, A., Clark, R., Barrera-Causil, C., Marmolejo-Ramos, F., Visvanathan, R. & Kitson, A., 21 Feb 2022, p. 1.Research output: Contribution to conference › Abstract › peer-review
-
Classification performance of clinical risk scoring in suspected acute coronary syndrome beyond a rule-out troponin profile
Khan, E., Lambrakis, K., Blyth, A., Seshadri, A., Edmonds, M. JR., Briffa, T., Cullen, L., Quinn, S., Horsfall, M., Morton, E., French, J. K., Papendick, C., Nelson, A. J. & Chew, D., Dec 2021, In: European Heart Journal: Acute Cardiovascular Care. 10, 9, p. 1038-1047 10 p.Research output: Contribution to journal › Article › peer-review
-
Research Program: Visibility and Technological Solutions for Frail, Homebound and Bedridden People - FHBP
Maria Alejandra Pinero de Plaza (Participant), Penelope McMillan (Participant), Alline Beleigoli (Participant), Michael Lawless (Participant), Alexandra Mudd (Participant), Mandy Archibald (Participant), Matthew Tieu (Participant), Rebecca Feo (Participant), Erin Morton (Participant), Belinda Lange (Participant), Mark Thompson (Participant), Danielle Taylor (Participant), Sue Gordon (Participant), Agustina Gancia (Participant), Sarah Hunter (Participant), Kathy Phelan (Participant), Robyn Clark (Participant), Ricky Buchanan (Participant), Renuka Visvanathan (Participant) & Alison Kitson (Participant)
Jun 2022 → Jun 2026Activity: Other activity types › Other
-
Interleukin 6 and Cardiovascular Outcomes in Patients With Chronic Kidney Disease and Chronic Coronary Syndrome. Batra G, Ghukasyan Lakic T, Lindbäck J, Held C, White HD, Stewart RAH, Koenig W, Cannon CP, Budaj A, Hagström E, Siegbahn A, Wallentin L; STABILITY Investigators. JAMA Cardiol. 2021 Dec 1;6(12):1440-1445. doi: 10.1001/jamacardio.2021.3079. PMID: 34431970 Clinical Trial.
Erin Morton (Other)
2021Activity: Other activity types › Other
-
Protease-Activated Receptor Antagonist for Reducing Cardiovascular Events - A Review on Vorapaxar. Gupta R, Lin M, Mehta A, Aedma SK, Shah R, Ranchal P, Vyas AV, Singh S, Kluck B, Combs WG, Patel NC. Curr Probl Cardiol. 2021 Oct 28:101035. doi: 10.1016/j.cpcardiol.2021.101035. Online ahead of print. PMID: 34718032 Review.
Erin Morton (Other)
2021Activity: Other activity types › Other
-
Risk markers of incident atrial fibrillation in patients with coronary heart disease. Tomasdottir M, Held C, Hadziosmanovic N, Westerbergh J, Lindbäck J, Aylward PE, Budaj A, Cannon CP, Engdahl J, Granger CB, Koenig W, Manolis AJ, Oldgren J, Stewart RAH, Svennberg E, Vinereanu D, White HD, Siegbahn A, Wallentin L, Hijazi Z. Am Heart J. 2021 Mar;233:92-101. doi: 10.1016/j.ahj.2020.12.016. Epub 2021 Jan 2. PMID: 33400910 Clinical Trial.
Erin Morton (Other)
2021Activity: Other activity types › Other